Area of research
Neurology · Ophthalmology
Research interest
Research interests include Intracranial Aneurysms: Treatment and Complications, Vascular Malformations Diagnosis and Treatment, Ocular Oncology and Treatments, and Cerebrovascular and Carotid Artery Diseases.
The River study: the first prospective multicenter trial of a novel venous sinus stent for the treatment of idiopathic intracranial hypertension
Biochemical measures of ovarian function in female survivors of retinoblastoma treated with intra-arterial melphalan: an initial report.
Intraarterial delivery of bevacizumab and cetuximab utilizing blood-brain barrier disruption in children with high-grade glioma and diffuse intrinsic pontine glioma: results of a phase I trial
Successful Treatment of Massive Choroidal Invasion in Retinoblastoma with Intra-arterial Chemotherapy (Ophthalmic Artery Chemosurgery).
A systematic review of surgical treatments of idiopathic intracranial hypertension (IIH)
Venous sinus stenting lowers the intracranial pressure in patients with idiopathic intracranial hypertension
Ten-year experience with ophthalmic artery chemosurgery: Ocular and recurrence-free survival
Intra-Arterial Chemotherapy (Ophthalmic Artery Chemosurgery) for Group D Retinoblastoma
Advanced Unilateral Retinoblastoma: The Impact of Ophthalmic Artery Chemosurgery on Enucleation Rate and Patient Survival at MSKCC
Intra-arterial delivery of AAV vectors to the mouse brain after mannitol mediated blood brain barrier disruption
Preoperative Embolization of Hypervascular Thoracic, Lumbar, and Sacral Spinal Column Tumors: Technique and Outcomes from a Single Center
Combined, Sequential Intravenous and Intra-Arterial Chemotherapy (Bridge Chemotherapy) for Young Infants with Retinoblastoma
Intra-Arterial Chemotherapy as a Treatment for Intraocular Retinoblastoma: Alternatives to Direct Ophthalmic Artery Catheterization
Three-drug intra-arterial chemotherapy using simultaneous carboplatin, topotecan and melphalan for intraocular retinoblastoma: preliminary results
Impact of operator and site experience on outcomes after angioplasty and stenting in the SAMMPRIS trial